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Toxicity of PBBs with Special Reference
to Porphyrinogenic Action and Spectral
Interaction with Hepatic Cytochrome
P-450
by J. J. T. W. A. Strik*
Some of the polyhalogenated aromatic compounds (PHAs) which are able to produce porphyria are
presently known as environmental contaminants. Chronic exposure to PHAs causes hepatic porphyria in
different species. Qualitatively PBBs act comparable to PHAs. An increase in accumulation of porphyrins
caused by PHAs is not simply related to an increase of 8-ALAS activity in liver. Heme cannot exert a
feedback when porphyria develops. Induction of P450 mediated drug enzymes is needed. The PHAs
interact with P-450 in vitro. The PHAs are converted into a reactive intermediate, not a known metabo-
lite, which depletes liver GSH and then becomes reactive to tissue structures. Mitochondria are damaged;
fluorescence of porphyrins is detected in the region of central veins where degenerative change in hepato-
cytes is most marked. A possible pathological change in the cell membrane permeability is assumed too. In
this porphyric stage uroporphyrinogen decarboxylase (urogen decarboxylase) is inhibited. The proportion
ofsteroid hormones product by ovaries and testes compared to each other are possibly involved in sensitivity
to porphyrinogenic compounds.
Introduction
Some polyhalogenated hydrocarbons, such as
hexachlorobenzene (HCB), (1) 1 ,4-dichloro-
benzene, 1,2,4-trichlorobenzene, polychlorinated
biphenyls (PCB) (different commercial brands),
hexachlorobiphenyls, 2,3,7,8-tetrachlorodibenzo-
p-dioxin, y-hexachlorocyclohexane, polybrom-
inated biphenyls (BP-6), methyl chloride, vinyl
chloride (2), and hexabromobenzene (3), are able to
produce porphyria in man and animals and pose
health hazards because of their presence in human
and animal food, in the work place, and in wildlife.
PBB is a strong porphyrinogenic compound in avian
systems. Compared to the porphyrinogenic action
of HCB and PCB, PBB is respectively 80 and 10
times more active (4, 5). A feature of the porphyria
evoked by these polyhalogenated aromatics is its
slow onset. A long chronic exposure is needed,
especially in mammals (6). This type of porphyria is
related to liver damage (7).
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Materials and Methods
Separate groups of adult Japanese quail were or-
ally dosed with gelatin capsules or fed diet contain-
ing PBB (BP-6 lot ml 1081). The parameter for por-
phyria consisted of macroscopic and microscopic
porphyrin fluorescence in the liver, bile, kidneys,
and blood; as well as 8-aminolevulinic acid synthase
(8-ALAS) activity in the liver and kidneys, analysis
of porphyrin methyl esters by means of thin-layer
chromatography, and determination of heme in liver
fractions. Furthermore the serum glutamic acid
dehydrogenase (GLDH) and glutamic acid
pyrotartaric acid transaminase (GPT) activities
were determined (4). To obtain P450/PBB binding
spectra, 105.000 g pellets of Japanese quail liver
were used (8).
Results
Influence of PBB on Heme Biosynthetic
Pathway
Table 1 shows the dose-effect correlation of 8-
ALAS activity in liver homogenate of female
Japanese quail, after administration PBB for seven
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Table 1. Formation of 8-aminolevulinic acid by liver homogenate, liver weights, and tissue fluorescence in Japanese quail orally dosed with
polybromobiphenyl for 7 days.
Tissue fluorescence incidence
PBB, ALA formed, Liver,
mg/kg nmole ALA/g g/100 g Animal Liver
body weight liver/hr" body weighta (macroscopic) Macroscopic Microscopic
0 88.4 2.93 0/5 0/5 0/5
25 207.6 3.65 0/5 0/5 0/5
50 259.0 3.65 0/5 0/5 0/5
100 355.0 3.69 0/5 0/5 1/5
250 271.3 5.27 2/5 2/5 3/5
500 Db 6.57 3/5 4/5 5/5
1000 Db 6.77 5/5 5/5 5/5
Mean values for 5 female birds per group.
b Animals died.
days. A maximum 8-ALAS activity was reached According to Table 4, hemin can not suppress the
with a dose of 100 mg/kg. This activity increase is porphyrin accumulation induced in the liver, bile,
two- to three-fold in value. Microscopic fluores- and kidneys by daily loading with 500 and 1000
cence in the liver was detected in three sacrificed mg/kg of PBB.
animals dosed 250 mg/kg and one sacrificed animal
dosed 100 mg/kg. Influence of PBB on Porphyrin Biosynthesis
Table 2 shows that daily PBB application reduces
the hepatic heme content (p < 0.05) prior to de- Table 5 shows that, starting with a daily dose of
velopment of hepatic porphyria. PBB of 100 mg/kg-day, porphyrin accumulation oc-
Table 3 shows that hemin can counteract the ele- curs in the liver and bile. Starting with a dose of 250
vated porphyrin production of the liver which is ex- mg/kg-day, the animals die with porphyrin ac-
creted by the bile and which was induced by a single cumulation in the liver, bile, and kidneys. No por-
PBB dose. phyrins were detected in the kidneys and blood of
Table 2. Influence of PBB on the heme content of the liver.a
PositiveHeme content vDuration of liver
No. of Dose, treatment, ,umole/g jmole/ gmole fluorescence
animals Substance mg/kg days of liver total liver /g albumen In animals
5 Control 3 0.72 + 0.08 1.77 ± 0.20 2.06 ± 0.14 0/5
6 PBB 1000 3 0.56 ± 0.07b 1.74 ± 0.12 1.73 ± 0.24 2/6
5 Control 5 0.56 ± 0.04 1.21 ± 0.13 1.72 ± 0.14 0/5
7 PBB 1000 5 0.41 +O.01b 1.45 ± 0.10 1.33 ± 0.09'1 3/7
aJapanese quail were dosed orally with 1000 mg/kg PBB per day. The heme content in the liver homogenate was determined after 3
and 5 days.
bp <0.05.
Table 3. Influence of hemin on the porphyrin accumulation in bile
and liver with single dose of PBB."
Positive
Duration of PBB fluorescence
No. of treatment, Dose, In animals
animals Substance hr mg/kg Bile Liver
5 Vehicle 18 0/5 0/5
5 Hemin 18 0/5 0/5
5 PBB + hemin 18 1000 2/5 1/5
5 PBB + vehicle 18 1000 5/5 0/5
a Japanese quail were dosed orally with PBB (1000 mg/kg).
Hemin was suspended in 0.001N NaOH; 10 Amole hemin/100 g
of animal was injected IP I hr before and 1 hr after dosing.
Porphyrin fluorescence was determined 17 hr after dosing as a
measure of the porphyrin accumulation.
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the three sacrificed animals, although they exhib-
ited liver and bile fluorescence. In the examined
organs, porphyrin accumulation occurred only
when the animals were moribund.
Macroscopic fluorescence of the whole body was
observed in all dead animals and in one moribund
specimen (1000, 500, and 250 mg/kg group). The
livers of these animals exhibited extremely strong
microscopic fluorescence. Furthermore, livers of
three sacrificed animals, from the 500, 250 and 100
mg/kg groups, showed a weak microscopic fluores-
cence.
In a subsequent experiment, five Japanese quail
were treated with a single dose of 500 mg/kg of
PBB. No porphyrins were detectable in the liver
and kidneys after 16 hr. The (pooled) bile contained
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Table 4. Influence of hemin on the accumulation of porphyrins In
bile, liver, and kidneys caused by dosing repeatedly with PBB.
Positive
PBB Duration fluorescence/
No. of dose of treatment, n animals
animals Substance mg/kg days Bile Liver Kidneys
4 Hemin 7 0/4 0/4 0/4
2 PBB 500 7 2/2 2/2 2/2
2 PBB 1000 7 2/2 2/2 2/2
4 PBB + hemin 500 7 4/4 4/4 4/4
4 PBB + hemin 1000 7 4/4 4/4 4/4
a Male Japanese quail were daily dosed orally with PBB (500
mg/kg and 1000 mg/kg) over a period of 7 days. Each day hemin
was administered IP just before the dosing (12.5 mg/100 g of
animal). After dosing for 7 days, the porphyrin accumulation in
bile, liver, and kidneys was determined with the aid of a fluores-
cence microscope.
Table 5. The dose dependence ofthe appearance and localization of
the earliest detectable porphyrin accumulation by PBB in various
organs in Japanese quail.a
dose, Positive fluorescence/n animals
mg/kg Bile Liver Blood Kidneys
0 0/5 0/5 0/5 0/5
25 0/5 0/5 0/5 0/5
50 0/5 0/5 0/5 0/5
100 1/5 1/5 0/5 0/5
250b 1/3 1/3 0/3 0/3
500' 1/1 1/1 0/1 0/1
lOOOd 0/0 0/0 0/0 0/0
a Female Japanese quail (35 total) were randomly divided into
groups of 5. One group served as a control group, receiving
empty capsules. The other gr6ups were dosed daily for 7 days
with different oral doses of PBB. Liver, bile, blood, and kidneys
were examined for macroscopic fluorescence of porphyrins.
b Two animals died within the 7-day test period, with fluores-
cence of the liver, bile and kidneys.
c Four animals died in the test period, with fluorescence of
liver, bile, and kidneys.
d Five animals died in the test period, with fluorescence of the
liver, bile, and kidneys.
porphyrins with 2, 3, 4, 6, and 8 COOH groups. The
experiment in Table 6 shows that PBB treatment
causes the development of porphyrin accumulation
in the kidneys and bile as well as in the liver.
Table 7 shows that with a daily application of 400
mg/kg of PBB for a period of 7 days, porphyrins
with 5-8 COOH groups accumulate in the bile and
feces, in addition to those with 2, 3, and 4 COOH
groups which are also detectable in the controls. In
the kidneys, no porphyrins were detectable in the
controls, while those of the PBB-treated animals
contained porphyrins with 4, 6, 7, and 8 COOH
groups. The liver of the controls and of the PBB-
treated animals contained porphyrins with 2 and
with 2 and 4 COOH groups, respectively. The ex-
periments of Table 8 indicate that porphyrins with
Table 6. The time dependence of the appearance and
loaliation of the earlest detectable porphyrin accumulation
by PBB in various organs in Japanese quail.a
PBB Duration of Positive fluorescence/n animalsdose, treatment,
mg/kg days Bile Liver Kidney Intestine
Control - 3 0/6 0/6 0/6 0/6
PBB 1000 3 6/6 Ob/6 6/6 3/6
Control - 5 0/6 0/6 0/6 0/6
PBB 1000 5 3/7 3Cn 7n 3/7
a Japanese quail (20 total) were randomly divided into four
groups. Two groups were dosed daily with 1000 mg/kg of PBB.
Two groups served as control. After 3 and 5 days, one control
and one treated group were examined for microscopic fluores-
cence of porphyrins in bile, liver, kidneys, and intestines.
b Two animals showed a few small spots of fluorescence.
c One animal showed a few small spots of fluorescence.
2, 4, and 8 COOH groups are detectable in the liver
as a result of PBB loading. The kidneys of these
animals which had died contained not only porphy-
rins with 4 and 8 but also with 6 and 7 COOH
groups; porphyrins with 2, 3, and 4 COOH groups
were detected in the bile.
Influence of PBB on Mitochondrial
Membrane Enzymes
Whether PBB porphyria develops before, during,
or after biochemically detectable liver lesions was
studied on the basis of the serum enzyme activities
of glutamic dehydrogenase and glutamic pyruvic
transaminase (SGLDH and SGPT). GLDH is a
typical mitochondrial enzyme and GPT is charac-
teristic cytoplasmic enzyme. Liver lesions result in
an elevated activity of one or both enzymes, de-
pending on the nature of the lesion.
The experiments in Table 9 demonstrate that
loading with 500 ppm PBB in the diet does not result
in a difference of SGPT activity (p > 0.05). Starting
with 10 days of PBB loading, the serum GLDH ac-
tivity is elevated (p < 0.05). After 10, 13, and 20
days, no porphyrin accumulation was found in the
liver of the PBB-loaded animals. Porphyrin ac-
cumulation in the bile was seen already after 5 days
in the PBB-loaded animals.
After 5 days ofPBB treatment (oral, as capsules),
SGLDH is elevated and porphyrin accumulation
occurs in the liver (Table 10).
Discussion
8-Aminolevulinic Acid Synthase
First of all, the existence of a relation in quail
liver between changes in ALAS activity and por-
phyrin accumulation in the liver was investigated.
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Table 7. Qualitatve differentiation of porphyrin methyl esters in PBB-loaded Japanese quail organs
by means of thin-layer chromatography.a
PBB Duration of Number of methyl ester groups in the porphyrinsb
dose, treatment,
mg/kg days Liver Bile Kidneys Feces
Control 7 2 2;3;4 ND 1;2;3;4;5
PBB 400 7 2;4 2;3;4;5;6;7;8 4;6;7;8 2;3;4;5;6;7;8
aFive Japanese quail were treated with 400 mg/kg-day ofPBB for 7 days. Five Japanese quail served as controls. No deaths occurred
during the treatment period. The condition of the PBB-treated animals did deteriorate, however (weight loss). After the 7-day period,
the porphyrin pattern in the liver, bile, kidneys, and feces was investigated by thin-layer chromatography. The liver and kidneys
exhibited microscopic fluorescence which was stronger in the kidneys than in the liver. Control animals were fed empty capsules.
b ND = not detectable; 2= protoporphyrin; 3 = 3-COOH porphyrin; 4= coproporphyrin; 5= penta-COOH porphyrin; 6 = hexa-
COOH porphyrin; 7 = hepta-COOH porphyrin; 8 = uroporphyrin.
Table 8. Qualitative differentiation of porphyrin methyl esters
from organs of Japanese quail receiving
PBB by thin-layer chromatography.a
Duration of Number of methyl ester
PBB treatment, groups in the porphyrinb
dose, mg/kg days Liver Bile Kidneys
500 8 4;8 4;7;8
9 ND ND
10 2;4;8 7;8
13 4 2;3;4 4;6;7;8
13 2 ND
14 ND 8
16 8 4;7;8
16 2;4 4
16 ND ND
a Japanese quail were subjected to 500 mg/kg of PBB in their
feed. Bile, liver, and kidneys of the animals that died were exam-
ined for the porphyrin patterns by means ofthin-layer chromatog-
raphy.
b ND = not detectable; 2 = protoporphyrin; 3 = 3-COOH
porphyrin; 4 = coproporphyrin; 6 = hexa-COOH porphyrin, 7 =
hepta-COOH porphyrin.
The fact that the three sacrificed animals with mi-
croscopic fluorescence in the liver had a ALAS ac-
tivity of 180-520 (nmole ALA/g liver/hr and that 12
of the 16 remaining PBB-treated animals had a
ALAS activity ranging between 180 and 520 nmole
ALA/g liver/hr while practically no microscopic
fluorescence was found in the livers of these ani-
mals suggests that these ALAS activities are not
correlated with hepatic porphyrin fluorescence
(Table 1). Protoporphyrin (PROTO), coproporphy-
rin (COPRO), and uroporphyrin (URO) were pres-
ent in the liver during treatment with the haloge-
nated aromatics, HCB (4) and PBB. This suggests
an increased heme synthesis, also because of an
increased P450 content (4) and a doubled ALAS
activity. ALAS activity is fast, but slightly in-
creased long before porphyria develops (see Fig. 1).
Porphyrin Accumulation
PBB-porphyria developed from completely
fluorescent fragments or the margins in the liver so
that the entire liver showed diffuse fluorescence.
PBB porphyria is characterized by an accumulation
of porphyrins with 5-8 COOH groups in the liver,
bile, and kidneys (Table 7). Later porphyrinogens
were found in the blood of these animals. The he-
patic and renal porphyrins thus must have formed in
situ. Porphyrins with 5-8 COOH groups normally
are not found in the bile. The presence of these
porphyrins in the bile of PBB-treated animals
suggests a disturbance of the excretion of these
porphyrins from the liver into the blood.
With PBB, porphyrin accumulation develops first
in the kidneys and gall bladder before it occurs in
the liver (Table 6).
The exclusive presence in the kidneys of porphy-
rins with 5, 6, and 7 COOH groups in the animals
treated with PBB which died evidently indicates an
uncoupling from the cytoplasmatic to the mito-
chondrial compartmentalization and an excretory
disturbance of the kidneys. Porphyrin accumulation
in the liver is the consequence of this.
Hepatic and renal porphyrin accumulation re-
quires prolonged loading with HCB (4) and PBB and
appears just before death. This was also found by de
Matteis et al. (9) in rabbits, by Vos et al. (10) in
Japanese quail, and by Simon et al. (11) in rats.
Porphyrin accumulation in the bile occurred within
a few days. The hepatic porphyrins appear much
later, while renal porphyrins occur only when the
animals are moribund. Evidently, the liver can ex-
crete porphyrins via the bile at the start of the PBB
loading period, but in a later stage this is no longer
possible, because the liver and kidneys are then
flooded with porphyrins.
The sensitivity of Japanese quail for the por-
phyrinogenic action of HCB (4) and PBB is remark-
able when compared to rats and mice. Japanese
quail can exhibit porphyrin accumulation in the bile
and liver as a result of HCB (4) and PBB within a
few days. In rats, the earliest porphyrin accumula-
tion in the liver occurs only after 8 weeks of HCB
treatment (11), and it can require more than 12
months in some cases (12). Two rats which we
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Table 9. Activity of serum glutamic acid dehydrogenase (SGLDH) and of serum glutamic acid pyrotartaric acid transaminase (SGPT)
during the porphyrinogenesis by PBB in the Japanese quail.a
Duration ofPoiiefursecnaimlNo. of Dose, treatment, SGPT, SGLDH, Positive fluorescence/n animals
animals Substance mg/kg days mU/ml mU/ml Bile Liver
6 Control 5 0.04 ± 0.02 2.52 ± 0.28 0/6 0/6
6 PBB 500 5 0.04 ± 0.02 3.10 ± 0.31 1/6 0/6
6 Control - 10 0.05 ± 0.02 0.0 0/6 0/6
6 PBB 500 10 0.03 ± 0.01 0.58 ± 0.14b 4/6 0/6
6 Control 13 0.06 ± 0.02 0.48 ± 0.14 0/6 0/6
6 PBB 500 13 0.06 ± 0.01 2.23 0O.27b 3/6 0/6
6 Control 20 0.08 ± 0.02 1.33 ± 0.20 0/6 0/6
6 PBB 500 20 0.07 ± 0.02 4.62 ± 0.39b 1/6 0/6
a Male Japanese quail were fed 500 ppm PBB. On different days the activities of GLDH and GPT were determined in the pooled
serum of three animals. The porphyrin accumulation in the bile, liver, and kidneys was detected with the fluorescence microscope.b p < 0.05; means + SEM
Table 10. Activity of SGLDH and of SGPT during porphyrinogenesis by PBB in Japanese quail.a
PBB Duration of . .
No. of dose, treatment, SGPT, SGLDH, Positive fluorescence/n animals
animals Substance mg/kg days mU/ml U/ml Bile Liver
6 Control 3 0.07 ± 0.01 0.98 ± 0.35 0/6 0/6
6 PBB 1000 3 0.08 ± 0.01 0.56 ± 0.41 6/6 0/6
6 Control - 5 0.04 ±0.03 0.36 0/6 0/6
7 PBB 1000 5 0.06 ± 0.01 0.96 + 0.54b 3/7 3/7
a Japanese quail were daily dosed orally, with capsules with 100 mg/kg PBB. On different days the activities of GLDH and GPT were
determnined in the combined serum of 2 or 3 animals. The porphyrin accumulation in the bile, liver and kidneys was detected with the
fluorescence microscope.
bp < 0.05; means + SEM
loaded with 500-1000 mg PBB/kg-day for one month
died without porphyrin fluorescence in the liver and
kidneys. Five kestrels (Falco tinnunculus) loaded
with PBB 250-1000 mg/kg for 9-16 days, did not
develop porphyria. Mice and guinea pigs cannot be
made porphyric with HCB but die with the loading
dose employed (9).
Heme
The stimulated heme formation detectable by an
elevated P450 content in the liver after HCB load-
ing (13-15) requires a higher ALA supply. After the
application of PBB, a decrease of the heme content
of liver can be observed. Not a single PBB-loaded
animal exhibited porphyrin accumulation in the
liver (Table 2).
The experiments in Table 3 show that porphyrin
production in the liver, which is excreted through
the bile and which was induced in the animals by a
single dose of PBB, can be returned to a normal
level by hemin. The heme deficiency induced by
PBB at this stage is eliminated by hemin. The in-
creased heme synthesis, detectable by the twofold
ALAS excretion through the bile is inhibited by
hemin. In this phase ofPBB loading, heme plays the
role of a regulator as was assumed by Granick (16).
Heme can exert a feedback.
The polyhalogenated aromatic PBB produces a
diminished heme content prior to the development
of porphyria. This occurs parallel to increased heme
synthesis. This can be detected by an increase or
constant heme content per total but enlarged liver
(Table 2). During treatment an immediate decrease
of heme (Table 2) and a twofold increase of ALAS
activity (Table 1) occur before hepatic porphyrin
accumulation becomes manifest. The increased
heme synthesis is relevant for the production of
cytochrome P450, which plays an important role in
the metabolism of exogenous substances. The in-
ducer thereby increases the possibilities for an ac-
celerated turnover of itself. This cannot be ac-
complished, because PBB is only sparingly
metabolized. For mixtures of Clophen A50 (PCB)
and PBB in Japanese quail liver microsomes, very
diffuse P450 binding spectra (type I spectral bind-
ing) were found, probably due to interactions of
several compounds which might counteract each
other (8). A possible metabolism of PBBs by the
liver P450 oxidation system is very slow. Chlori-
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FIGURE 1. Mechanism of action of hepatic porphyria caused by polyhalogenated compounds (PHA).
nated phenols, such as metabolites of hexa-
chlorobenzene (17) converted cytochrome P-450
into P-420 in vitro (8). Indications of increased heme
utilization caused by polyhalogenated aromatics
can also be found in the literature. Wada et al. (13)
found an elevated P450 content and a twofold in-
crease of ALAS activity with 2 days of HCB load-
ing. The same was observed by Sweeney et al. (18)
(see Fig. 1). The experiments of Stonard (14),
Stonard and Zenov (15), Rajamanickam et al. (19)
and Strik and Koeman (20) confirm the increase of
the hemoprotein P450 content under the influence
of HCB (4). The animals were in good condition
during these experiments. There was no indication
of hepatic porphyrin accumulation. Rajamanickam
et al. (19) also found an elevated incorporation of
glycine and ALA in heme and P-450.
Polychlorobiphenyl (PCB) and phenobarbital in-
duce an elevated P450 content (5, 21) and some
microsomal enzyme reactions, such as demethyla-
tion, reduction and hydroxylation in the liver (21).
This indicates that the polyhalogenated aromatics
(HCB, PBB, and PCB) stimulate the liver to in-
creased heme synthesis as a reaction to the exoge-
nous substances. This is necessary for the produc-
tion of the hemoprotein P450 which plays an im-
portant role in the metabolism of exogenous sub-
stances. This results in a heme deficiency which has
a derepressing effect on the neosynthesis of ALAS
or a deinhibiting effect on its activity. This in-
creased ALAS activity is implicitly related with in-
creased heme synthesis (Table 1). A continuous de-
crease of the heme content by the application of
PBB (Table 2) may be due to a disturbance in pro-
toporphyrin synthesis. Oxidized porphyrinogens ac-
cumulate and sufficient protoporphyrin is no longer
produced. A consequence of this is a further de-
crease of the heme content, possibly paralleled by an
accumulation of iron. This iron can no longer be
effectively utilized by incorporation in protoporphy-
rin. According to Bach et al. (22), HCB porphyria in
rats is paralleled by a storage of iron and accumula-
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destruction
(5)
PHA-OH
(3)
tion of porphyrins in the liver.
In contrast, the heme deficiency and excessive
porphyrin accumulation in the liver, bile, and kid-
neys resulting from 7 days ofPBB loading apparently
can not be inhibited by hemin (Table 4).
Heme could not block uroporphyrin accumula-
tion from added ALA in presence of polyhaloge-
nated aromatic compounds in chick embryo liver
cell culture (23). Heme can not exert a feedback
when porphyria develops. Hemin does not play the
role which it fulfills with a few doses of PBB when
heme synthesis is increased in this stage, and there
is no indication of porphyria. In this second phase
of PBB loading, when porphyria is involved, por-
phyrin or heme synthesis as well as porphyrin by-
product elimination are damaged to such a degree
that hemin is not capable of counteracting the por-
phyria and then can no longer exercise its feedback
function. A disturbed protoporphyrin synthesis is
also supported by the finding of Taljaard et al. (24)
that uroporphyrinogen decarboxylation activity was
reduced to zero in HCB rats with a completely por-
phyric liver. According to these authors (24) and
Table 7, protoporphyrin synthesis is arrested in the
stage of decarboxylation of the porphyrinogens.
Heme also plays a central regulatory function in
PBB-stimulated heme synthesis. This is no longer
the case when porphyria has developed due to these
substances.
Reactive Intermediate
According to Sinclair and Granick (23), there is
an induction of a metabolizing system. This requires
protein synthesis, since it is blocked by cyclo-
heximide. The polyhalogenated aromatic is con-
verted by the induced drug metabolizing enzyme
system to a metabolite (see Fig. l), since known
inhibitors of cytochrome P-450 action (e.g. SKF-
525A) prevent uroporphyrin formation. Fur-
thermore iron (P450-dependent iron?) is required at
some reaction step for the formation of the metabo-
lite that causes uroporphyrin accumulation. The
active compound is not a known metabolite, but is
probably an intermediate (Fig. 1), because known
metabolites of HCB (17) did not cause any por-
phyria in Japanese quail (2) but can convert P450 in
vitro into P420 (8) (Fig. 1).
Brodie (25) indicates that centrilobular liver ne-
crosis produced by bromobenzene is mediated
through a chemically active metabolite, which is
formed oxidatively by enzymes in liver micro-
somes. The active intermediate of bromobenzene is
an epoxide which reacts with glutathione (GSH).
After liver GSH has been sufficiently depleted, the
epoxide then reacts with tissue macromolecules in-
April 1978
cluding proteins (Fig. 1). Experiments were carried
out to test if GSH depletion correlates with liver
porphyria caused by polyhalogenated aromatics in
Japanese quail.
Mitochondrial Enzymes
PBB, administered in capsules, produce an im-
mediate biochemically detectable liver lesion. This
becomes manifest by an elevated SGLDH activity
(1, 26) (Tables 9 and 10).
Pietschmann and Raab (27) and Simon et al. (11)
also found an elevation of SGPT, and Ivanov (28)
found an increase in y-glutamyltranspeptidase
(y-GT) in rats made porphyric with HCB. However,
their experiments do not reveal whether the ob-
served liver damage began before or after the onset
of porphyria (i.e., hepatic porphyrin accumulation).
The liver lesion observed occurs before the ani-
mals exhibit hepatic porphyrin accumulation and
before a morphological liver lesion can be detected.
This may indicate that PBB-porphyria is a form
which develops on or after damage of the liver has
occurred. Because serum GLDH (SGLDH), as a
typical mitochondrial enzyme, is elevated while
SGPT is not, PBB may possibly act by damaging the
membranes and particularly the mitochondrial
membrane. A possible pathological change in the
cell membrane permeability caused by HCB has
also been postulated (29). The affinity of
polyhalogenated aromatics for membrane struc-
tures which are rich in lipids may be assumed be-
cause of their lipophilic character. The affinity of
PBB for lipid-rich membrane structures can also
become manifest at the start of treatment with these
substances. The membrane structure, of which cy-
tochrome P450 is a part, does not become func-
tional by interaction of PBB with HCB (4). P450 is
released from its structure and the free P450 is im-
mediately metabolized by biliverdin. An increased
degradation of P450 demands a new supply. Heme
availability or heme synthesis is adjusted to this.
This may represent a possible explanation of the
increased heme synthesis caused by polyhaloge-
nated aromatics. It can be recognized by a two- to
threefold increase in ALAS activity and increased
release of by-products of heme synthesis (porphy-
rins) in the liver. This becomes manifest as an ele-
vated porphyrin accumulation in the bile, which is
the first to be detected.
The observation of Sweeney et al. (18) that he-
patic mitochondria diminish during HCB loading
also suggests a mitochondrial effect of HCB. The
cytoplasmatic enzymes of heme synthesis can then
still function normally and the cytoplasmatic por-
phyrins (with 4-8 COOH groups) accumulate in the
liver (Table 7).
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Uroporphyrinogen Decarboxylase
Polyhalogenated aromatic compounds evoke a
cytoplasmic porphyria characterized by porphyrins
with 7 and 8 carboxyl groups in the liver, 5, 6, 7, and
8 carboxyl groups in the bile, and 6, 7, and 8 car-
boxyl groups in the kidney (2, 4). Due to the marked
increase in higher carboxylated porphyrins in the
liver and urine in this experimental porphyria, it
was felt that there may be a failure to decarboxylate
uroporphyrinogen normally (9). In fact uropor-
phyrinogen decarboxylase activity could not be
detected in the livers of HCB-treated animals (24,
30).
Evidence (Fig. 1) was obtained for an instable
intermediate that is generated in the liver from
chlorinated hydrocarbons which inhibits uropor-
phyrinogen decarboxylase, thus causing uropor-
phyrin to accumulate. The data suggest that the in-
termediate may be a hydroxylated derivative (23).
Sexual Hormones
The relative proportions of steroid hormones
produced by the ovaries and the testes are possibly
involved in sensitivity of organisms to por-
phyrinogenic compounds (4, 31-33). Nonfunctional
dearrangement of smooth endoplasmatic reticulum
(SER) is manifested in whorl formation. This
phenomenon is found only in male rats (20). The
formation of a possible porphyrinogenic inter-
mediate may be slowed down by the nonfunctional
rearrangement of SER.
Conclusion
PPBs (4) increase the heme utilization by cyto-
plasmic hemoproteins (the cytochromes). An in-
creased demand for heme by these hemoproteins
can be filled by increased heme synthesis, detecta-
ble by a more than about two fold increase in ALAS
activity in the liver and porphyrin by-products in
the bile. This increased heme synthesis can be in-
hibited by hemin.
PBB porphyria (1) is preceded by liver and kidney
damage. Accumulation of porphyrins in the liver is
not solely due to an increase of ALAS activity, but
rather to drug enzyme induction and the formation
of an reactive intermediate which causes cen-
trilobular liver damage and ultimately porphyria.
The hepatic mitochondria decrease in number and
are damaged (elevated SGLDH); the proliferated
endoplasmic reticulum, including the hemoprotein
P-450, is no longer capable of normal activity;
uroporphyrinogen decarboxylase activity is re-
duced to zero; renal porphyrins accumulate and are
excreted in the liver and via the bile; in addition
there are many morphological changes.
Porphyria in Humans
Some polyhalogenated aromatics are able to pro-
duce liver porphyria in experimental animals (34).
Chronic hepatic porphyria in humans caused by
polyhalogenated hydrocarbons is known.
Chlorodibenzodioxins (35, 36), hexachlorobenzene
(37), methyl chloride (38) and vinyl chloride (39)
evoke increased total urinary porphyrin values of
81-8778 ,ug/l. and an abnormal porphyrin pattern in
urine.
A group which has been exposed to PBB, a pow-
erful porphyrinogen, over the past several years has
been identified. The sole purpose of the investiga-
tion was to assess liver health, using urine porphy-
rin excretion as an indicator in a population of farm
families which, was presumed, received the highest
doses ofPBB. No attempt has been made to analyze
or assess any other PBB-produced conditions,
symptoms, or illnesses unrelated to liver damage.
Because of the macroscopic fluorescence of the
urines examined, total porphyrin values of more
than 100 ,ug/l., and abnormal thin-layer chromatog-
raphy porphyrin patterns (containing porphyrins
with 7, 6, or 5 COOH groups), it was concluded that
in 26 to 45% of the study group, members of the
farm families exposed to PBB indications for the
presence of coproporphyrinuria and chronic hepatic
porphyria type A could be detected. These
symptoms may be indicative of slight liver damage
(40).
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